BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 26, 2022 3:03pm

62 Views

Post# 35050944

BIOV~IS THIS THE LEAKED VOLUME? WE GOT 3 MILLION INCOMING!!

C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com

15:00:52 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOV - C	2.0	0.235	·	0.24	38.0	0.24	+0.015	6.7	2,604.2	562	566	0.23 0.25 0.195	0.395 0.085	14:42:24	Oct 14	15 min RT 2¢
CSE - C	2.0	0.235	·	0.24	38.0	0.24	+0.015	6.7	890.8	190	245	0.23 0.25 0.195	0.395 0.085	14:42:24		15 min
NEO ATS - U						0.24	+0.015	6.7	1,529.5	334	260	0.22 0.25 0.195		14:42:24		15 min
Omega - O						0.24	+0.015	6.7	165.0	35	48	0.22 0.245 0.20		14:36:54		15 min
CX2 - H						0.235	+0.01	4.4	18.5	4	9	0.21 0.235 0.20		14:05:57		15 min
CXD - D						0.225			0.2		2			Jul 04		15 min
TriAct - M						0.225			0.2		2					15 min